230 related articles for article (PubMed ID: 1301586)
1. BCG versus cytotoxic chemotherapy in the treatment of superficial bladder tumors.
Boccon-Gibod L
Prog Clin Biol Res; 1992; 378():55-7. PubMed ID: 1301586
[No Abstract] [Full Text] [Related]
2. New approaches to intravesical chemo-immunotherapy in superficial bladder cancer.
van der Meijden AP
Prog Clin Biol Res; 1992; 378():95-101. PubMed ID: 1301591
[No Abstract] [Full Text] [Related]
3. BCG in the management of superficial bladder cancer.
Guinan P; Richardson C; Hanna M; Rubenstein M
Prog Clin Biol Res; 1989; 303():447-53. PubMed ID: 2675002
[TBL] [Abstract][Full Text] [Related]
4. [Intravesical chemotherapy of superficial bladder tumors].
Matsumura Y
Gan To Kagaku Ryoho; 1989 Feb; 16(2):193-8. PubMed ID: 2645832
[TBL] [Abstract][Full Text] [Related]
5. Editorial comment on: Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder cancer.
Evans CP
Eur Urol; 2007 Oct; 52(4):1129-30. PubMed ID: 17383082
[No Abstract] [Full Text] [Related]
6. [A comparative clinical trial of UFT medication and intravesical BCG in the recurrence of superficial bladder cancer. Study Group of UFT and BCG adjuvant therapy for bladder cancer].
Oda H; Seki N; Nabeshima S; Oda T; Nishio S; Yokoyama M; Iwata H; Takeuchi M; Matsumoto A; Terado T
Gan To Kagaku Ryoho; 1990 Oct; 17(10):2051-5. PubMed ID: 2221929
[TBL] [Abstract][Full Text] [Related]
7. BCG-RIVM versus BCG-Tice versus mitomycin-C in superficial bladder cancer. Rationale, design, and interim analysis of the trial of the South-East Cooperative Urological Group, The Netherlands.
Witjes WP; van der Meijden PM; Roos EP; Witjes JA; Steerenberg PA; Doesburg W; Debruyne FM
Prog Clin Biol Res; 1992; 378():59-67. PubMed ID: 1301587
[No Abstract] [Full Text] [Related]
8. [Intravesical therapy: Influence on superficial bladder cancer recurrence].
García Rodríguez J; Fernández Gómez JM; Escaf Barmadah S; González Alvarez RC; Jalón Monzón A; Martínez Gómez FJ; Sánchez Trilla A; Regadera Sejas J
Arch Esp Urol; 2007; 60(1):36-43. PubMed ID: 17408170
[TBL] [Abstract][Full Text] [Related]
9. Intravesical chemotherapy in non-muscle-invasive bladder cancer: what schedule and duration of treatment?
Sylvester RJ
Eur Urol; 2007 Oct; 52(4):951-3; discussion 953-4. PubMed ID: 17374437
[No Abstract] [Full Text] [Related]
10. Impact of intravesical chemotherapy versus BCG immunotherapy on recurrence of superficial transitional cell carcinoma of the bladder: metaanalytic reevaluation.
Huncharek M; Kupelnick B
Am J Clin Oncol; 2003 Aug; 26(4):402-7. PubMed ID: 12902895
[TBL] [Abstract][Full Text] [Related]
11. Risk-adapted use of intravesical chemotherapy.
Lerner SP; Au JL
BJU Int; 2008 Nov; 102(9 Pt B):1247-53. PubMed ID: 19035889
[No Abstract] [Full Text] [Related]
12. [BCG therapy. Its role in the treatment of tumors of the bladder].
Patard JJ; Chopin DK; Abbou CC
Ann Urol (Paris); 1995; 29(5):292-3. PubMed ID: 8638911
[No Abstract] [Full Text] [Related]
13. [Medical treatment of urothelial tumors of the bladder].
Ferrière JP; Dionet C; Dauplat J; Boiteux JP; Plagne R; Giraud B
Ann Urol (Paris); 1988; 22(4):229-34. PubMed ID: 3056230
[TBL] [Abstract][Full Text] [Related]
14. [Intravesical instillation in the treatment of superficial tumors of the bladder].
Chopin DK
Prog Urol; 1998 Apr; 8(2):268-73. PubMed ID: 9615941
[TBL] [Abstract][Full Text] [Related]
15. Superficial bladder cancer--treatment approach.
Abi-Aad A; Biquet P; Penders L
Acta Urol Belg; 1996 May; 64(2):19-24. PubMed ID: 8701801
[No Abstract] [Full Text] [Related]
16. Mitomycin-C and BCG in intravesical chemotherapy and immunotherapy of superficial bladder cancer. Finnbladder Research Group.
Rintala E; Jauhiainen K; Alfthan O
Prog Clin Biol Res; 1989; 310():271-4. PubMed ID: 2505270
[No Abstract] [Full Text] [Related]
17. [Intravesical bacillus Calmette-Guerin therapy for superficial bladder tumor: experience of 13 cases].
Okuno H; Shirahase T; Kihara Y; Arai Y
Hinyokika Kiyo; 1989 Sep; 35(9):1503-7. PubMed ID: 2816616
[TBL] [Abstract][Full Text] [Related]
18. BCG-(RIVM) versus mitomycin intravesical therapy in patients with superficial bladder cancer. EORTC GU Group and the Dutch South-East Collaborative Group.
Debruyne FM; van der Meijden AP; Franssen MP
Prog Clin Biol Res; 1989; 303():435-46. PubMed ID: 2506556
[No Abstract] [Full Text] [Related]
19. Intravesical chemotherapy in the management of superficial bladder tumors.
Schulman CC
Prog Clin Biol Res; 1984; 153():275-85. PubMed ID: 6433356
[No Abstract] [Full Text] [Related]
20. [Superficial bladder cancer: prophylaxis of recurrence and progression].
Miyanaga N; Akaza H; Koiso K
Gan To Kagaku Ryoho; 1991 Nov; 18(14):2369-74. PubMed ID: 1719939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]